Browsing bySubjectCancer immunotherapy

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 11 of 11

Issue DateTitleAuthor(s)Type
2022A novel kinase inhibitor ax-0085 inhibits interferon-γ-mediated induction of pd-l1 expression and promotes immune reaction to lung adenocarcinoma cells김재상Article
2025Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy김광명Article
2024Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy김진성; 이용현; 김광명Article
2020Combined hybrid structure of siRNA tailed IVT mRNA (ChriST mRNA) for enhancing DC maturation and subsequent anticancer T cell immunity이혁진; 이규리Article
2026Esterase-responsive albumin-binding PROTACmediated BRD4 degradation for cancer immunotherapy김진성; 김광명Article
2021In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer윤주영Article
2022Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity김광명Article
2024Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy김광명Article
2026Quantitative systems pharmacology models: unleashing their potential in cancer immunotherapy이용현Review
2024Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy김광명Review
2025Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumors임선아Article

BROWSE